Friday, April 14, 2017 1:26:48 AM
Future markets for vitiligo - view into the future of clinuvel as long as the admission studies are successful and market approval will get achieved. The figures are calculated by extrapolation of US-data (not based on country-specific data sources) ...
What do you think this will bring to us? Does it take still much longer now before afamelanotide is granted for Vitiligo now it's granted for EPP within the EU?
Clinuvel a safe investment.
Clinuvel isn't a start-up anymore, it's doing business. It's a grown-up Biotech company. Clinuvel undervalued.
Afamelanotide for EPP, granted in the EU. The only thing the FDA has to do is signing. The EMA did already the homework for them. What's keeping it up! There is absolutely no reason for that anymore.
It's better they fuse together.
Still $0,10 behind the australian closingprice yesterday and $0,25 behind UR9 at the Frankfurter borse! It's time America wakes up, the train is leaving.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM